Atomo Diagnostics Limited (AT1) Earnings Call Transcripts
Atomo Diagnostics Limited's Latest Earnings Call - Q1 FY2026
In Q1 2026, Aroundtown SA reported net rental income of EUR 297 million, slightly above the EUR 295 million from Q1 2025, driven by a 3% like-for-like rental growth. Adjusted EBITDA remained stable at EUR 250 million, while FFO I decreased by 8% to EUR 70 million, attributed to higher finance expenses. Notably, management raised its FFO I guidance for the fiscal year 2026 to a range of EUR 275 million to EUR 305 million, reflecting the positive impact of increased ownership in Grand City Properties (GCP). The share buyback program is nearing completion, further enhancing per share metrics and signaling strong capital management.
Reported metrics
| Metric | Value |
|---|---|
| Net Rental Income | EUR 297 million (beat) |
| Adjusted EBITDA | EUR 250 million (inline) |
| FFO I | EUR 70 million (miss) |
| FFO I Guidance | EUR 275 million to EUR 305 million (positive) |
| EPRA NTA per Share | EUR 8 (positive) |
| Liquidity | EUR 4.1 billion (positive) |
Guidance from management
Management raised its 2026 FFO I guidance to EUR 275 million to EUR 305 million, reflecting the positive impact of the increased stake in GCP and ongoing operational growth. Per share guidance remains unchanged at EUR 0.24 to EUR 0.27.
What management said
This concludes our presentation. As always, you can find further material in our appendix. With that, we would like to start the Q&A. Before we invite your direct telephone questions, we would like to answer questions that we have received by e-mail prior to this call. For simplicity reasons, the team have taken liberty to group similar questions in order to answer as many questions as possible. Allow me now to read...
Year-to-date, including after the reporting date, we have signed disposals amounting to circa EUR 300 million, representing around half of our properties held for sale. After the reporting period, we completed disposals in the amount of circa EUR 270 million, primarily consisting of the company's Pentabranded hotels, which includes 11 hotels in Germany, Belgium and France. These hotel properties were previously class...
What analysts pressed on
Analysts expressed concerns regarding the sluggish recovery of the German office market and potential impacts on tenant demand. There were also questions about the sustainability of rental growth amidst macroeconomic uncertainties and the effectiveness of the conversion strategy in the current environment.
Main topics on the call
- Increased Stake in GCP — Aroundtown successfully increased its stake in GCP from 62.5% to 81.5%, which is expected to add approximately EUR 35 million to annualized FFO I. Management stated, "The transaction was FFO per share neutral on day 1 wi...
- Share Buyback Program — The company has executed 93% of its EUR 250 million share buyback program, which is expected to enhance FFO per share. The buyback is being conducted at a significant discount to NAV, with management noting, "We executed...
- Stable Operational Performance — The portfolio demonstrated solid operational performance with a total like-for-like rental growth of 3%. Residential assets achieved a growth of 3.7%, while hotels saw a growth of 4%, indicating resilience in the living ...
- Guidance Update — Management raised its FFO I guidance for 2026 to EUR 275 million to EUR 305 million, up from previous expectations, reflecting the positive impact of the GCP stake increase. The per share guidance remains unchanged at EU...
Read the full Atomo Diagnostics Limited transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Atomo Diagnostics Limited
Atomo Diagnostics Limited (AT1) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on ASX and is based in AU. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 35 calls on record spanning March 26, 2020 to July 24, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 35 Atomo Diagnostics Limited earnings call transcripts on record, spanning March 26, 2020 to July 24, 2026. Based on this history, Atomo Diagnostics Limited reports quarterly. The most recent call on file is dated July 24, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- AT1
- Exchange
- ASX
- Country
- AU
- Sector
- Health Care
- Calls on record
- 35
- First call
- March 26, 2020
- Most recent
- July 24, 2026
- Reporting cadence
- quarterly